BIO Liquidation Heatmap & Analytics

As of 2026-10-17 16:00 UTC, BIO carries $60K of short-liquidation exposure on Hyperliquid, the 100th-largest of 160 tracked markets. Over the last 4 hours, long exposure fell $745.71 (-1.69%) and short exposure fell $2K (-3.69%). The Advanced balance cohort flipped net short (73% → 10% long). The Mid-Tier balance cohort flipped net long (18% → 83% long).

Bio Protocol (BIO) is trading at $0.0244, down -1.81% over the past 24 hours (24h range $0.0240–$0.0252). Across HyperLiquid, BIO shows $43K in long-liquidation exposure (23 positions) versus $69K short (16 positions), on $111K of open interest — a strongly bullish liquidation skew. The cross-exchange 8-hour funding rate is +0.0093% (10.13% annualized, slightly positive) across 6 venues.

This BIO liquidation heatmap is sourced directly from a HyperLiquid node, so every wallet is included. It maps cumulative long and short liquidation pressure across price levels, highlights the stop-order clusters protecting longs and shorts, and shows where forced exits are most likely to cascade — alongside aggregated orderbook depth, the cross-exchange funding rate, and a trader-cohort profitability breakdown over 24-hour, 7-day, and 30-day windows.